Actavis opens Beijing office

Actavis opens Beijing office
Actavis has established a regional office for China at Beijing's Youth Plaza Office Building.

Actavis' Beijing office will primarily handle registrations for imported products and related regulatory issues, as well as sales activities.

The Beijing office will be responsible for further developing Actavis' business in China. The Company is already established in Guangzhou in Guangdong province, where it operates a manufacturing site. About 80% of Actavis' sales in China have been in Guangdong, but the company‘s ambitious plans for growth in the Chinese market over the coming years include an expansion into other provinces, with the addition of the Beijing office as a first step.

The Beijing office is located on the Third Ring Road which is the busiest section of the Central Business District in the Chinese capital.

The Actavis (Foshan) Pharmaceutical Co., Ltd. is a joint venture between the Actavis Group and Foshan Chanbende Development Co., Ltd.

The Guangdong manufacturing site employs 300 people producing antibiotics and other products, particularly for use in the treatment of the digestive and cardiovascular system.

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.